-
Je něco špatně v tomto záznamu ?
In search of the cell biology for self- versus non-self- recognition
S. Apcher, B. Vojtesek, R. Fahraeus
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy, práce podpořená grantem
- MeSH
- antigeny * MeSH
- histokompatibilita - antigeny třídy I * MeSH
- lidé MeSH
- peptidy MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Several of today's cancer treatments are based on the immune system's capacity to detect and destroy cells expressing neoantigens on major histocompatibility class-I molecules (MHC-I). Despite this, we still do not know the cell biology behind how antigenic peptide substrates (APSs) for the MHC-I pathway are produced. Indeed, there are few research fields with so many divergent views as the one concerning the source of APSs. This is quite remarkable considering their fundamental role in the immune systems' capacity to detect and destroy virus-infected or transformed cells. A better understanding of the processes generating APSs and how these are regulated will shed light on the evolution of self-recognition and provide new targets for therapeutic intervention. We discuss the search for the elusive source of MHC-I peptides and highlight the cell biology that is still missing to explain how they are synthesised and where they come from.
Department of Medical Biosciences Building 6M Umeå University 901 85 Umeå Sweden
Inserm UMRS1131 Institut de Génétique Moléculaire Université Paris 7 Hôpital St Louis France
Institut Gustave Roussy Université Paris Sud UMR 1015 Villejuif France
RECAMO Masaryk Memorial Cancer Institute Zluty kopec 7 65653 Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016742
- 003
- CZ-PrNML
- 005
- 20231026105602.0
- 007
- ta
- 008
- 231013s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.coi.2023.102334 $2 doi
- 035 __
- $a (PubMed)37210933
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Apcher, Sebastien $u Institut Gustave Roussy, Université Paris Sud, UMR 1015, Villejuif, France
- 245 10
- $a In search of the cell biology for self- versus non-self- recognition / $c S. Apcher, B. Vojtesek, R. Fahraeus
- 520 9_
- $a Several of today's cancer treatments are based on the immune system's capacity to detect and destroy cells expressing neoantigens on major histocompatibility class-I molecules (MHC-I). Despite this, we still do not know the cell biology behind how antigenic peptide substrates (APSs) for the MHC-I pathway are produced. Indeed, there are few research fields with so many divergent views as the one concerning the source of APSs. This is quite remarkable considering their fundamental role in the immune systems' capacity to detect and destroy virus-infected or transformed cells. A better understanding of the processes generating APSs and how these are regulated will shed light on the evolution of self-recognition and provide new targets for therapeutic intervention. We discuss the search for the elusive source of MHC-I peptides and highlight the cell biology that is still missing to explain how they are synthesised and where they come from.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a histokompatibilita - antigeny třídy I $7 D015395
- 650 12
- $a antigeny $7 D000941
- 650 _2
- $a peptidy $7 D010455
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vojtesek, Borek $u RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653 Brno, Czech Republic
- 700 1_
- $a Fahraeus, Robin $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, France; Department of Medical Biosciences, Building 6M, Umeå University, 901 85 Umeå, Sweden; RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653 Brno, Czech Republic. Electronic address: robin.fahraeus@inserm.fr
- 773 0_
- $w MED00001285 $t Current opinion in immunology $x 1879-0372 $g Roč. 83, č. - (2023), s. 102334
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37210933 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026105556 $b ABA008
- 999 __
- $a ok $b bmc $g 2000330 $s 1203104
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 83 $c - $d 102334 $e 20230519 $i 1879-0372 $m Current opinion in immunology $n Curr Opin Immunol $x MED00001285
- LZP __
- $a Pubmed-20231013